ALEXANDRIA, Va., June 6 -- United States Patent no. 12,280,103, issued on April 22, was assigned to Sichuan Clover Biopharmaceuticals Inc. (Chengdu, China).
"Coronavirus vaccine compositions, methods, and uses thereof" was invented by Peng Liang (Chengdu Sichuan, China) and Joshua Liang (Chengdu Sichuan, China).
According to the abstract* released by the U.S. Patent & Trademark Office: "The present disclosure relates in some aspects to immunogenic compositions including recombinant peptides and proteins comprising coronavirus viral antigens and immunogens, e.g., coronavirus S protein peptides. In some aspects, the immunogenic composition comprises a secreted fusion protein comprising a soluble coronavirus viral antigen joined by in-frame ...